These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3889971)

  • 21. Learning disabilities. Challenging service.
    Matthews DR
    Nurs Times; 1995 Jun 7-13; 91(23):59-61. PubMed ID: 7603881
    [No Abstract]   [Full Text] [Related]  

  • 22. Implementation of an interdisciplinary psychotropic drug review process for community-based facilities.
    Lepler S; Hodas A; Cotter-Mack A
    Ment Retard; 1993 Oct; 31(5):307-15. PubMed ID: 8271941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy and mental retardation/developmental disability: a bibliography. (Special emphasis on non-institutionalized populations).
    Reatig N
    Psychopharmacol Bull; 1985; 21(2):329-33. PubMed ID: 3889973
    [No Abstract]   [Full Text] [Related]  

  • 24. Issues and future research directions of pharmacotherapy in mental retardation.
    Schroeder SR
    Psychopharmacol Bull; 1985; 21(2):323-6. PubMed ID: 4001293
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy with psychotropic agents of mentally retarded children].
    Kinze W
    Z Arztl Fortbild (Jena); 1983; 77(9):402-4. PubMed ID: 6880286
    [No Abstract]   [Full Text] [Related]  

  • 26. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical challenge of a complex population: seizures, anticonvulsants, mental retardation, and institutions.
    Rubin L
    Am J Ment Retard; 1989 May; 93(6):603-4. PubMed ID: 2719842
    [No Abstract]   [Full Text] [Related]  

  • 29. Trimonam and mental retardation.
    Huston I; Swett C; Cole JO
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):70-2. PubMed ID: 401715
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical care of the deinstitutionalized mentally retarded.
    Merker EL; Wernsing DH
    Am Fam Physician; 1984 Apr; 29(4):228-33. PubMed ID: 6232838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
    Stolker JJ; Koedoot PJ; Heerdink ER; Leufkens HG; Nolen WA
    Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic process of movement in residential settings.
    Altman BM; Cunningham PJ
    Am J Ment Retard; 1993 Sep; 98(2):304-16. PubMed ID: 8398089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emergency role of the residential facility in the treatment & care of the community retardate.
    Sluyter FV
    Ment Retard; 1969 Oct; 7(5):45-8. PubMed ID: 5346585
    [No Abstract]   [Full Text] [Related]  

  • 34. A viable role for retardation institutions: the road to self-destruction.
    Thurman SK; Thiele RL
    Ment Retard; 1973 Apr; 11(2):21-3. PubMed ID: 4786289
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing patterns of psychoactive drug use with the mentally retarded.
    White AJ
    N Z Med J; 1983 Sep; 96(739):686-8. PubMed ID: 6577342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in mental health services for people with intellectual disability in residential care in Israel 1998-2004.
    Merrick J; Kandel I; Stawski M
    Isr J Psychiatry Relat Sci; 2006; 43(4):281-4. PubMed ID: 17338448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Problems of mutagenic side effects of psychotropic substances. 1. Psychotropic drugs, narcotics, anticonvulsants].
    Gebhart E
    Fortschr Med; 1979 Jan; 97(2):45-8. PubMed ID: 759282
    [No Abstract]   [Full Text] [Related]  

  • 39. The community and the institution.
    Martin GE
    Ohio State Med J; 1974 Feb; 70(2):98-101. PubMed ID: 4811444
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of states' utilization of large residential settings for persons with mental retardation.
    Rotholz DA; Massey PS
    Ment Retard; 1996 Oct; 34(5):303-11. PubMed ID: 8908995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.